Yajun Duan Selected Research

25-hydroxycholesterol 3-sulfate

12/2018

Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yajun Duan Research Topics

Disease

32	Atherosclerosis 01/2022 - 06/2012
19	Inflammation (Inflammations) 01/2022 - 04/2014
12	Neoplasms (Cancer) 12/2022 - 04/2008
8	Fatty Liver 01/2022 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2015
6	Breast Neoplasms (Breast Cancer) 12/2018 - 05/2015
5	Vascular Calcification 01/2022 - 10/2018
4	Insulin Resistance 01/2021 - 01/2019
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2014
4	Coronary Disease (Coronary Heart Disease) 01/2017 - 05/2014
3	Fibrosis (Cirrhosis) 03/2021 - 11/2019
3	Thrombosis (Thrombus) 01/2021 - 01/2018
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 01/2018
3	Non-alcoholic Fatty Liver Disease 12/2020 - 02/2018
3	Vascular Diseases (Vascular Disease) 03/2020 - 01/2019
3	Hypertriglyceridemia 01/2020 - 04/2015
3	Dyslipidemias (Dyslipidemia) 01/2020 - 04/2015
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2020
2	Obesity 01/2022 - 01/2020
2	Sepsis (Septicemia) 12/2021 - 08/2021
2	Virus Diseases (Viral Diseases) 11/2021 - 12/2018
2	Wounds and Injuries (Trauma) 06/2021 - 01/2017
2	Cardiotoxicity 06/2021 - 12/2020
2	Atrophy 03/2021 - 01/2021
2	Cholestasis 03/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 11/2019
2	Heart Failure 12/2020 - 03/2020
2	Body Weight (Weight, Body) 12/2020 - 06/2015
2	Hypercholesterolemia 11/2020 - 01/2017
2	Necrosis 01/2020 - 11/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 12/2018 - 01/2016
2	Carcinogenesis 12/2018 - 06/2013
2	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2015 - 01/2015

Drug/Important Bio-Agent (IBA)

17	Apolipoproteins E (ApoE)IBA 01/2022 - 04/2015
10	LigandsIBA 01/2022 - 12/2010
10	LipidsIBA 01/2022 - 06/2013
9	Capsules (Microcapsules)IBA 01/2021 - 01/2015
9	Liver X ReceptorsIBA 01/2021 - 12/2012
7	T0901317IBA 01/2021 - 04/2014
7	naoxintongIBA 01/2021 - 01/2015
6	CholesterolIBA 01/2019 - 12/2012
5	U 0126 (UO 126)IBA 01/2022 - 02/2015
5	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 06/2015
5	CollagenIBA 03/2021 - 05/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2020
4	ApolipoproteinsIBA 01/2022 - 05/2014
4	Transcription Factors (Transcription Factor)IBA 06/2021 - 12/2012
4	Rosiglitazone (Avandia)FDA Link 01/2021 - 11/2019
4	LongShengZhiIBA 03/2020 - 01/2019
4	oxidized low density lipoproteinIBA 01/2020 - 12/2012
4	Tamoxifen FDA LinkGeneric 12/2018 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
3	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2018
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2020
3	Monoamine Oxidase (MAO)IBA 11/2021 - 01/2019
3	AntioxidantsIBA 06/2021 - 09/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 03/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 11/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021 - 11/2019
3	Collagen Type I (Type I Collagen)IBA 03/2021 - 11/2019
3	Peptides (Polypeptides)IBA 01/2021 - 12/2010
3	InterferonsIBA 01/2021 - 02/2015
3	Estrogen ReceptorsIBA 12/2018 - 10/2018
3	Teniposide (VM 26)FDA Link 12/2018 - 06/2013
3	trioctyl phosphine oxide (TOPO)IBA 12/2018 - 06/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018 - 08/2015
3	buchang naoxintongIBA 01/2017 - 01/2015
3	Fatty Acid-Binding ProteinsIBA 08/2015 - 06/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 12/2020
2	Biological ProductsIBA 12/2021 - 01/2021
2	EnzymesIBA 06/2021 - 03/2020
2	Glutathione PeroxidaseIBA 03/2021 - 01/2020
2	CatalaseIBA 03/2021 - 03/2020
2	Toll-Like Receptor 4IBA 03/2021 - 01/2021
2	Urethane (Ethyl Carbamate)IBA 01/2021 - 01/2016
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2020
2	HydrogelsIBA 01/2021 - 01/2021
2	CytokinesIBA 01/2021 - 11/2019
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 05/2014
2	AdiponectinIBA 12/2020 - 01/2017
2	asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamideIBA 12/2020 - 01/2017
2	Adenosine Monophosphate (AMP)IBA 12/2020 - 02/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2010
2	Carthamus tinctorius Honghua extractIBA 01/2020 - 05/2014
2	CarrageenanIBA 01/2019 - 01/2018
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2018 - 06/2013
2	danhongIBA 06/2015 - 05/2014
2	Etoposide (VP 16)FDA LinkGeneric 06/2015 - 06/2013
2	G250 monoclonal antibodyIBA 02/2010 - 04/2008
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2022
1	roxadustatIBA 01/2022
1	ChemokinesIBA 01/2022

Therapy/Procedure

7	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2021 - 01/2019
4	Therapeutics 01/2021 - 04/2015
2	Oral Administration 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 12/2018 - 12/2010